BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10408528)

  • 1. Von Hippel-Lindau disease: how does one gene cause multiple tumors?
    Roach ES
    Neurology; 1999 Jul; 53(1):7-8. PubMed ID: 10408528
    [No Abstract]   [Full Text] [Related]  

  • 2. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
    Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
    Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
    Montera M; Bellone E; Ajmar F; Mandich P
    Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.
    Los M; Kerckhaert OA; Zewald R; van Amstel HK; Voest EE
    J Natl Cancer Inst; 2000 Oct; 92(20):1688-9. PubMed ID: 11036115
    [No Abstract]   [Full Text] [Related]  

  • 5. Von Hippel-Lindau tumor suppressor protein and transcription elongation: new insights into regulation of gene expression.
    Bertherat J
    Eur J Endocrinol; 1996 Feb; 134(2):157, 159. PubMed ID: 8630511
    [No Abstract]   [Full Text] [Related]  

  • 6. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
    Gnarra JR; Duan DR; Weng Y; Humphrey JS; Chen DY; Lee S; Pause A; Dudley CF; Latif F; Kuzmin I; Schmidt L; Duh FM; Stackhouse T; Chen F; Kishida T; Wei MH; Lerman MI; Zbar B; Klausner RD; Linehan WM
    Biochim Biophys Acta; 1996 Mar; 1242(3):201-10. PubMed ID: 8603073
    [No Abstract]   [Full Text] [Related]  

  • 8. [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene].
    Soussi T
    Bull Cancer; 2000 Nov; 87(11):771-2. PubMed ID: 11190567
    [No Abstract]   [Full Text] [Related]  

  • 9. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
    Humphrey JS; Klausner RD; Linehan WM
    Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471
    [No Abstract]   [Full Text] [Related]  

  • 10. Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.
    Shuin T; Kondo K; Ashida S; Okuda H; Yoshida M; Kanno H; Yao M
    Contrib Nephrol; 1999; 128():1-10. PubMed ID: 10597373
    [No Abstract]   [Full Text] [Related]  

  • 11. The von Hippel-Lindau tumor suppressor gene.
    Kondo K; Kaelin WG
    Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-based diagnosis of the von Hippel-Lindau syndrome.
    Patel RJ; Appukuttan B; Ott S; Wang X; Stout JT
    Am J Ophthalmol; 2000 Feb; 129(2):258-60. PubMed ID: 10682986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene symbol: VHL. Disease: von Hippel-Lindau syndrome.
    Di Maria E; Ciotti P
    Hum Genet; 2004 Jul; 115(2):171. PubMed ID: 15300977
    [No Abstract]   [Full Text] [Related]  

  • 14. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hereditary forms of pancreatic neuroendocrine tumors.
    DeLellis RA
    Adv Anat Pathol; 1999 May; 6(3):149-53. PubMed ID: 10342012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients.
    Moore PS; Antonello D; Martignoni G; Racchini C; Ventrucci M; Scarpa A
    Hum Mutat; 2000 Jun; 15(6):582. PubMed ID: 10862095
    [No Abstract]   [Full Text] [Related]  

  • 17. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Hippel-Lindau disease: the role of gene analysis in affected families.
    Riegler P; Huber W; Corradini R; Neumann HP; Glaesker S; Sessa A
    Nephron; 2000 Jan; 84(1):95-7. PubMed ID: 10644921
    [No Abstract]   [Full Text] [Related]  

  • 19. A PCR generated BsaJ I RFLP in the promoter of the von Hippel-Lindau disease (VHL) tumour suppressor gene.
    Geil L; Semenova E; Lerman MI; Kuzmin I
    Mol Cell Probes; 1998 Oct; 12(5):343-4. PubMed ID: 9778462
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene symbol: VHL. Disease: Von-Hippel-Lindau syndrome.
    Baker DW; Cherches IM; Rothberg PG
    Hum Genet; 2000 Jun; 106(6):671. PubMed ID: 10942119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.